Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP 400mg), packa...

FDA Drug Recall #D-0033-2025 — Class III — September 25, 2024

Recall Summary

Recall Number D-0033-2025
Classification Class III — Low risk
Date Initiated September 25, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Denison Pharmaceuticals, LLC
Location Lincoln, RI
Product Type Drugs
Quantity 72,648 bottles

Product Description

Adult Cough and Chest Congestion (Dextromethorphan HBr USP 20 mg, Guaifenesin USP 400mg), packaged in 4 oz bottles further package in cartons, Distributed by: Genexa Inc., Alanta, GA, 30318, NDC-69676-0077-9, UPC Code # 850015736155

Reason for Recall

Crystallization: Lack of uniformity - a change in texture, chunky, grainy, and small crystal substances inside the bottles.

Distribution Pattern

Product was distributed to two accounts that may have distributed the product further to the Retail Level.

Lot / Code Information

Lot# 0104V, Exp 07/2025; 0106V, Exp 09/2024

Other Recalls from Denison Pharmaceuticals, LLC

Recall # Classification Product Date
D-0273-2025 Class II Zapzyt, Acne Treatment Gel, 10% benzoyl peroxid... Feb 24, 2025
D-0034-2025 Class III Kids' Cough and Chest Congestion (Dextromethorp... Sep 25, 2024
D-0557-2024 Class II Little Remedies Gas Relief Drops (Simethicone/A... May 28, 2024
D-0774-2023 Class II Pin-Away PYRENTAL PAMOATE (Pyrantel base 50 mg ... May 3, 2023
D-0775-2023 Class II Safe tussin PM, NIGHT TIME Cough Relief, (Dextr... May 3, 2023

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.